Two Georgia men share their experiences with breast cancer, from diagnosis and treatment to the importance of recognizing symptoms and advocating for their health.

FDA approves Tukysa maintenance therapy with Herceptin and Perjeta, extending progression-free survival by over eight months for many patients.

Everlywell will offer patients access to Clairity Breast, an AI tool approved by the FDA to predict a woman’s five-year risk of breast cancer based on imaging.

Translating laboratory discoveries into clinical benefit for patients with breast cancer increasingly depends on combining genomic profiling with newer tools, including patient-derived functional models and artificial intelligence (AI).

Mike Landsberg of Plainview is the executive chef and co-owner of Jackson Hall in East Islip. As a male breast cancer survivor he's made it his mission to help and raise awareness. NewsdayTV's Geoff Bansen reports.

Patients with heavily pretreated hormone receptor (HR)-positive breast cancer lived twice as long without disease progression with the novel antibody-drug conjugate (ADC) izalontamab brengitecan (iza-bren), a randomized trial from China showed.

The second reconstructive surgery follows the singer’s May mastectomy amid her breast cancer diagnosis

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening approach is appropriate.